Using an unsupervised mass cytometry approach, Galli et al. demonstrated a CD4+ T-cell signature in MS blood that was classified by GM-CSF, IFNγ, and VLA-4 expression [77]. The gene discussed is CD4; the disease is myeloid sarcoma.